The method 9, wherein said oral administration is characterized by substantially no increase in {HEAD ~ serum levels} of aspartate aminotransferase , {TAIL ~ alanine aminotransferase} , or both 
of
The method 9 , wherein said oral administration is characterized by substantially no increase in { HEAD ~ serum levels } of aspartate aminotransferase , { TAIL ~ alanine aminotransferase } , or both
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH